Last updated
    Medline Industries
    Medical equipment and supplies

    Medline Industries

    United States flagUnited States

    "Making healthcare run better"

    Founded 1966 Northfield, Illinois CEO: Jim Boyle
    Community

    About

    Medline Industries is the largest provider of medical-surgical products and supply chain solutions in the United States. Founded in 1966 by brothers Jim and Jon Mills in Evanston, Illinois, the company started with a modest 12,000 square feet of warehouse space and one loading dock. Today it operates in over 100 countries, employs 45,000 people, and generated $28.4 billion in revenue in fiscal 2025. Medline manufactures and distributes more than 550,000 SKUs, ranging from exam gloves and surgical gowns to advanced wound care and infection prevention products.

    The company's business model is a hybrid: it both manufactures its own branded products and distributes third-party goods, giving it a unique competitive edge. Medline's Prime Vendor relationships, where it becomes the exclusive primary supplier for a healthcare system's entire continuum of care, create deep integration and sticky partnerships. These relationships, combined with its scale and supply chain expertise, have made Medline an indispensable backbone of the healthcare supply chain.

    In June 2021, a consortium of private equity firms, Blackstone, Carlyle, and Hellman & Friedman, acquired Medline in a landmark leveraged buyout valued at $34 billion. The company subsequently went public on the Nasdaq in 2025 under the ticker MDLN and made its first appearance on the Fortune 500 list in 2026. Despite its massive scale, Medline remains guided by the Mills family, with Charlie Mills serving as chair and Jim Boyle as CEO.

    Products & Sub-brands

    Medical and surgical suppliesExam glovesWound care productsUrology productsInfection prevention productsTextiles and surgical gownsSupply chain solutionsInventory management services

    Frequently Asked Questions

    Who owns Medline?
    Medline was owned by the Mills family for most of its history. In 2021, a consortium of private equity firms, Blackstone, Carlyle, and Hellman & Friedman, acquired the company in a $34 billion leveraged buyout. The company subsequently went public on the Nasdaq in 2025 under the ticker MDLN.
    Who is the CEO of Medline?
    The CEO of Medline is Jim Boyle. He leads the company alongside Chair Charlie Mills, a member of the founding family. The company is headquartered in Northfield, Illinois, and employs over 45,000 people worldwide.
    How much is Medline worth?
    Medline was valued at $34 billion in its 2021 private equity acquisition. Ahead of its IPO in late 2025, it was reported to have an anticipated valuation of around $50 billion. The company generated $28.4 billion in revenue in its 2025 fiscal year.
    What is the difference between Medline and Cardinal Health?
    Both are major medical supply distributors, but Medline is the largest in the U.S. and is a hybrid manufacturer and distributor, producing many of its own branded products. Cardinal Health is a pure distributor and a larger pharmaceutical distributor, whereas Medline focuses more heavily on medical-surgical supplies.
    Is Medline still in business?
    Yes, Medline is very much in business and is the largest provider of medical-surgical products in the United States. In fact, the company recently went public, made its first appearance on the Fortune 500 list in 2026, and employs over 45,000 people worldwide.

    Keywords

    medical supplieshealthcare distributionmedical-surgical productssupply chain solutionsexam gloveswound careinfection preventionprime vendorhospital suppliesMedline IPO

    Sources

    Company Info

    Founded
    1966
    Founder
    Jim Mills, Jon Mills
    CEO
    Jim Boyle
    Headquarters
    Northfield, Illinois
    Industry
    Medical equipment and supplies
    Revenue
    28400000000
    Employees
    45000
    Stock Ticker
    MDLN (Nasdaq)

    Official Website

    www.medline.com/

    Join the community

    fans discussing